HomeMy WebLinkAboutR2025-225 Fully ExeccutedBOARD OF COUNTY COMMISSIONERS
COUNTY OF KITTITAS
STATE OF WASHINGTON
RESOLUTTON No. 2o2s- 2a5
A RESOLUTION TO AUTHORIZE EXECUTION OF AN INTERLOCAL
AGREEMENT BETWEEN KITTITAS COUNTY AND CITY OF ELLENSBURG FOR
THE POOLING OF OPIOID FUNDS RESULTING FROM THE SETTLEMENT OF
CLAIMS AGAINST PHARMACEUTICAL SUPPLY CHAIN PARTICIPANTS
WHEREAS, the Interlocal Cooperation Act, as amended, and codified in Chaptet 39.34 of the
Revised Code of Washington ("RCW'), provides for public agencies to enter
into agreements for joint or cooperative action authorized under that chapter;
and
WHEREAS, this Interlocal Agreement (ILA) is between Kittitas County (KC) and the City of
Ellensburg (COE) for the pooling of funds received by the COE pursuant to its
execution of the One Washington Memorandum of Understanding with those
received by Kittitas County pursuant to its execution of the same agreement.
COE and KC are local governments who have executed both the One
Washington Mutual Memorandum of Understanding Between Washington
Municipalities and the Memorandum of Understanding between the Greater
Columbia Region Municipalities to Establish an Opioid Abatement Counsel to
establish a framework for the distribution and oversight of Opioid Funds (as the
term is defined in both agreements); and
WHEREAS, the City of Ellensburg desires to pool the funds it receives with the funds
Kittitas County receives in order to best serve the residents of Ellensburg and
Kittitas County; and
WHEREAS, it is mutually beneficial for the COE and KC to enter into this ILA; and
WHEREAS. the term of the ILA shall be from the last date of signature until the COE no
longer receives Opioid Funds pursuant to the above listed agreements, unless the
ILA is terminatedearly or its term is extended as provided within this ILA; and
WHEREAS. KC and COE agree to designate a set amount of Opioid Funds available from its
settlement account for each funding cycle, will provide staff support and
perform other duties as set forth in ILA, which is attached hereto and
incorporated bY reference; and
WHEREAS, Both parties agree that each will follow the requirement of the underlying
MOUs that each has executed and agreed to abide by; and
WHEREAS, Both parties agree to fund the Kittitas County Public Health Department Harm
Reduction Program outside the public request for proposal process I the amount
of $100.000.00 per year, for five (5) years, beginning January 1,2026; and
WHEREAS, the point of contact for the City of Ellensburg with be Heidi Behrends
?_
Cerniwey, City Manager, and the point of contact for Kittitas County is Kasey
Knutson, Human Services Manager for Kittitas County Public Health
DePartment.
NOW, THEREFORE BE IT RESOLVED that the Board of county commissioners, in the
best interest of the public, does hereby authorize the Boards' signature on an Interlocal
Agreement between Kittitas county and the city of Ellensburg.
D ArEDthis 18%day of 2025, at Ellensburg, Washington.
BOARD OF COI.INTY COMMISSIONERS
KITTITAS COI.]NTY, WASHINGTON
C
of the
APPROVED AS TO FORM
(--
Prosecutor/Deputy Prosecutor
INTERLOCAL AGREEMENT
Between
KITTITAS COUNTY
and
The City of Ellensburg
for
Pooling Of Opioid Funds Resulting from the Settlement of Claims Against Pharmaceutical Supply Chain
Participants
This lnterlocal Agreement (hereinafter the "Agreement") is entered into by and between Kittitas
County, a municipal corporation of the State of Washington, and the City of Ellensburg, a municipal
corporation of the State of Washington for the pooling of funds received by the City of Ellensburg
pursuant to its execution of the One Washington Memorandum of Understanding with those received
by Kittitas County.
WHEREAS, the parties are public agencies as defined in the lnterlocalCooperation Act (RCW
39.34), and wish to enter into this Agreement pursuant to the provisions of said Act, which allows public
agencies to cooperate on a basis of mutual advantage to provide services and facilities in an optimized
manner to address the needs of local communities; and
WHEREAS, the people of the State of Washington have been harmed by entities within the
pharmaceutical supply chain who manufacture, distribute and dispense prescription opioids; and
WHEREAS, Washington State and certain local governments have and may continue to engage in
litigation against entities within the pharmaceutical supply chain for their roles in the State's opioid
epidemic resulting in large opioid distributors paying the State to end the litigation over multiple
settlement agreements; and
WHEREAS, the governing body of each party to this Agreement has approved such party's
involvement in the cooperative interlocal activities as described herein; and
WHEREAS, Kittitas County and the City of Ellensburg are participating local governments who
have executed both the One Washington Memorandum of Understanding (MOU) Between Washington
Municipalities and the Memorandum of Understanding between the Greater Columbia Region
Municipalities to Establish an Opioid Abatement Council to establish a framework for the distribution
and oversight of Opioid Funds (as that term is defined in both such agreements); and
WHEREAS, local governments that are parties to those agreements maintain full discretion over
the use and distribution of their allocation of Opioid Funds, provided only LO% of those funds may be
used for administrative costs and the balance must be used solely for Approved Purposes as that term is
defined in the One Washington MOU; and
WHEREAS, the City of Ellensburg desires to pool the Opioid Settlement Funds it receives
pursuant to the above referenced MOUs with Kittitas County in order to best serve the residents of
Ellensburg and Kittitas County; and
WHEREAS; it is mutually beneficial for the parties to enter into this Agreement at this time;
NOW, THEREFORE, Kittitas County and the City of Ellensburg hereby agree as follows:
L. Purpose. The purpose of this Agreement is to effectively pool Opioid Settlement Funds to
increase the benefit of opioid abatement strategies to the citizens of Ellensburg and Kittitas
County.
2. Term. The term of this Agreement shall be from the last date of signature until the City of
Ellensburg no longer receives Opioid Funds pursuant to the One Washington MOU and the
Greater Columbia Region Opioid Abatement Council MOU, unless the Agreement is terminated
early or its term is extended as provided herein.
3. Responsibilities of the Parties.
Kittitas Cou ntv's Responsibilities:
l.
Iil.
Kittitas County agrees to designate a set amount of Opioid Funds available from
their settlement account for each funding cycle. This set amount may be the
same or differ from the amount set by the City of Ellensburg.
Kittitas County will provide staff support to create, implement, and oversee a
public request for proposal process to elicit project and activity proposals.
Once each party has set an amount of available Opioid Funds, Kittitas County
will select three staff to participate in the Opioid Settlement review group to
score funding applications using an agreed upon scoring matrix and recommend
projects and activities for approval by the legislative authorities for each Party.
Staff may not represent departments or divisions applying for funding.
At the time in which funding awards have been approved by the respective
legislative authorities, Kittitas County agrees to accept the designated Opioid
Funds from the City of Ellensburg and utilize them to pay for eligible projects
and activities approved for funding.
Kittitas County shall provide contract oversight, including invoicing and
monitoring of deliverables, of allfunding awards using pooled Opioid
Settlement funds.
IV
Kittitas County will provide regular status reports and fiscal updates to the City
of Ellensburg on the progress of funding recipients and will provide ad hoc
updates to the City of Ellensburg as requested.
Kittitas County shall receive and retain the City of Ellensburg's portion of Opioid
Funds that may be allocated for administrative costs (L0% of total).
Kittitas County agrees to submit all reporting required by the regional Opioid
Abatement Council (OAC) showing how the City of Ellensburg's forwarded funds
have been expended on behalf of the City of Ellensburg. Kittitas County will
provide copies of the filed reports to the City of Ellensburg after they have been
accepted by the regional Opioid Abatement Council.
Kittitas County agrees to hold 10% of funds for transfer to the OAC, as required
per the OAC MOU.
Kittitas County agrees to pay up to 10% of OAC funds held to the OAC on behalf
of both Kittitas County and the City of Ellensburg upon invoicing from the OAC.
Any City of Ellensburg funds from a designated funding cycle that remain
unspent (community awards or OAC hold) will be retained by Kittitas County for
the sole purpose of being applied to the subsequent funding cycle. lf the
unspent funds are from the final funding cycle, Kittitas County will provide these
funds back to the City of Ellensburg at their request.
b. Citv of Ellensburs's Responsibilities:
V.
vt.
vilt.
vil
ilt.
tv
ix.
X.
The City of Ellensburg agrees to designate a set amount of Opioid Funds
available from their settlement account for each funding cycle. This set amount
may be the same or differ from the amount set by Kittitas County. The City of
Ellensburg also agrees to designate an additional 10% (based on the amount set
by the City of Ellensburg) to be held by Kittitas County for payment to the OAC.
Once each party has set an amount of available Opioid Funds, the City of
Ellensburg will select two staff to participate in the Opioid Settlement review
group to score and recommend projects and activities for approval by the
legislative authorities for each Party. Staff may not represent departments or
divisions applying for funding.
At the time in which funding awards have been approved by the respective
legislative authorities, the City of Ellensburg agrees to promptly provide the
County with the full designated amount of funds for that funding cycle.
The City of Ellensburg shall notify the regional Opioid Abatement Council, in
writing, that their Opioid Funds will be transferred to Kittitas County.
il,
c.Joint Responsibilities of the Parties:
ilt.
Both parties will ensure that all requirements of the One Washington MOU
found in Exhibit A of this agreement and the Greater Columbia Opioid
Abatement Council MOU found in Exhibit B of this agreement specific to each
individual entity are met.
Both parties agree to support the funding priorities established by the
community-based input of the Community Health lmprovement Plan and One
Washington MOU Opioid Abatement Strategies Crosswalk Analysis, found in
Exhibit C of this agreement.
Both parties agree to fund the Kittitas County Public Health Department Harm
Reduction Program outside of the public request for proposals process in the
total amount of 5L00,000 per year for five years beginning January L,2026. fhe
City of Ellensburg will contribute S10,000 each year, and Kittitas County will
contribute 590,000 each year. The Harm Reduction program meets funding
priorities and is recognized by both parties as a critical prevention and response
support to residents of the City of Ellensburg and Kittitas County.
Both parties will coordinate the timely presentation of funding
recommendations to their respective legislative authorities for final approval.
No funds will be granted until approvalfrom both parties has been granted via
resolutions by the respective legislative authorities. lf a legislative authority
chooses to deny a funding recommendation, no joint funding will be provided to
that applicant. However, each party retains the right to provide separate
funding to applicants, outside of this Agreement. Both parties will work
collaboratively to share results and outcomes of funding awards publicly.
4. Points of Contact. The parties' addresses and points of contact for any notices to be delivered
under this Agreement are as follows:
KITTITAS COUNW CITY OF ELLENSBURG
i.
ll
IV
v.
205 West 5th Ave, Suite 108
Ellensburg, WA 98925
Kasey Knutson
Human Services Manager
Kittitas County Public Health Department
509-962-7515
kasey. knutson @co. kittitas.wa.us
501 N Anderson
Ellensburg, WA 98925
Heidi Behrends Cerniwey
City Manager
City Manager's Office
509-962-722L
cerniweyh@ellensbu rgwa.gov
5. Disbursement of Funds to Elisible Proiects. Projects selected for funding will contract directly
with Kittitas County. All invoiced expenses will be reviewed by Kittitas County for allowability,
and any expenses found to be unallowable will be denied. Allfunded projects will be required to
submit progress reports and updates on achievement of goals and deliverables.
6. Budset and Pavment. Settlement funds will be disbursed in several phases, based on availability
of funds. At such a point when both parties determine sufficient settlement funds have been
received, a Request for Proposals (RFP) will be released to the community. The RFP will have a
set maximum amount to be distributed to be determined by settlement funds received and in
the possession of each party. Both parties will agree to the total amount available for the phase.
Kittitas County will provide staff support to administer the RFP. Once proposals have been
reviewed for eligibility and scored by the Opioid Settlement Review group, the group will vote
on proposals to recommend for funding and will create formal recommendations based on
majority vote.
Once each party's legislative body has approved funding proposals for execution, Kittitas County
will invoice the City of Ellensburg for the total agreed upon amount for the entire disbursement
phase. Kittitas County willthen administer funds to the selected agencies through monthly
reimbursement of allowable costs incurred.
7. Administration. For the purposes of RCW 39.34.030(4)(a), the points of contact as listed in
section 4. above shall be the administrators of this Agreement. No separate legal or
administrative entity is created by this Agreement. No joint budget or financing method is
created by this Agreement; each party will manage its own financing and budgeting processes
hereunder. This Agreement will be posted online or filed with the county auditor as required by
RCW 39.34.040.
8. Termination. This Agreement may be terminated at any time by mutual written agreement of
the parties. Additionally, this Agreement may be terminated unilaterally at any time by either
party with thirty (30) days' written notice to the other party. Termination of this Agreement by
any means provided herein shall not excuse either party's performance of its obligations
hereunder through the effective date of termination.
9. Modification. The parties may modify the terms of this Agreement through one or more formal
written amendments, signed by both parties.
10. Notices. Written notices required or permitted to be provided by one party to the other pafi
under this Agreement may be provided by personal delivery, legal courier service, or certified
mail, postage prepaid and return receipt requested. Notice may be provided by regularfirst
class mail if simultaneous notice is provided by email. Notices given by a party shall be provided
to the other party's point of contact as listed in Section 4. of this Agreement.
11. lnsurance. Each party shall maintain general liability coverage at all times, and such liability
coverage documents shall be made available to the other party on an annual basis. Each party
may choose to share the other party's coverage documents with their insurance carrier or risk
pool. The failure of any insurance carrier or self-insured pooling organization to agree to or
follow the terms of this section shall not relieve any individual party from its obligations under
this Agreement.
12. Propertv. The parties do not anticipate acquiring jointly owned personal or real property under
this Agreement. Any personal property of a party used in the performance of this Agreement in
the possession of the other party shall be returned to the owner promptly upon completion of
each task for which such personal property was utilized.
13. Records. Each party shall preserve and maintain its records relating to this Agreement for six (6)
years after termination or expiration of the Agreement. Such records shall be subject to
inspection, review and audit by either party, the Washington State Auditot's Office, or any other
entity as required by law.
14. lndemnification. Each party will be responsible for its own acts and/or omissions in its
performance under this Agreement, and the acts and/or omissions of its employees, agents,
officials, and registered volunteers. Neither party shall be responsible to the other party for the
acts or omissions of persons or entities not a party to this Agreement. The parties agree to
maintain a consolidated defense to claims made against them and to reserve all indemnity
claims against each other until after liability to the claimant and damages, if any, are
adjudicated. lf any claim is resolved by voluntary settlement and the parties cannot agree upon
apportionment of damages and defense costs, they shall submit apportionment to binding
arbitration. The indemnification obligations of the parties shall not be limited in any way by the
Washington State lndustrial lnsurance Act, RCW Title 51, or by application of any other
workmen's compensation act, disability benefit act or other employee benefit act. Each party
hereby expressly waives any immunity afforded by such acts to the extent required by its
obligations to indemnify, defend and hbtO harmless the other party. A party's waiver of
immunity does not extend to claims made by its employees directly against the party as
employer. The foregoing indemnification obligations of the parties are a material inducement
to enter into this Agreement and have been mutually negotiated.
15. lndependent Capacitv. Each party to this Agreement shall act in an independent capacity and
notasanagentorrepresentativeoftheotherparty. Theemployeesoragentsof eachparty
who are engaged in the performance of this Agreement shall continue to be the employees or
agents of that party, and shall not be considered for any purpose to be the employees or agents
of the other party.
1-6. Severabilitv. lf any provision of this Agreement shall be held invalid, such invalidity shall not
affect the other provisions of this Agreement that can be given effect without the invalid
provision, if such remainder is consistent with applicable law and with the fundamental purpose
of this Agreement, and to this end the provisions of this Agreement are declared to be
severable.
17. Waiver. The waiver by a party of any default or breach of this Agreement, or the failure of a
party to enforce any provision hereof or to exercise any right or privilege hereunder, shall not be
deemed to waive any prior or subsequent breach or default, the enforcement of any provision
hereof, orthe exercise of any right or privilege hereunder, unless otherwise stated in a signed
writing by the party granting such waiver.
18. Disputes. ln the event of a dispute between the parties relating to this Agreement, the parties
agree to make a good faith attempt to resolve such dispute informally, prior to the
commencement of any legal action or arbitration.
19. Governins Law. This Agreement shall be governed by the laws of the State of Washington.
20. Force Maieure. ln the event of a forced delay in performance by a party of its obligations under
this Agreement, due to causes beyond that party's reasonable control, including but not limited
to natural disasters, epidemics, embargoes, war, insurrection, riots, or strikes, such party's time
for performance under this Agreement shall be extended for the period of the forced delay.
21. Entire Agreement. This Agreement constitutes the entire agreement between the parties and
supersedes any and all other agreements, understandings, negotiations and discussions, oral or
written, express or implied, relating to the subject matter hereof.
lN WITNESS WHEREOF, this Agreement has been executed by and on behalf of the parties through their
authorized representatives, effective as of the latest date written below.
KITTITAS COUNTY
MISSIONERS
ABSENT
Vice-Chair
mtss
CITY OF ELLENSBURG
City Manager
sig re
Printed Name
Title
a
SEAI
Attest:
Date Date:
EXHIBIT A
ONE WASHINGTON MEMORANDIUM OF UNDERSTANDING BETWEEN WASHINGTON MUNICIPALITIES
ONE WASHINGTON MEMORAI\DUM OF UI\DERSTANDING BETWEEN
WASHINGTON MUMCIPALITIES
Whereas, the people of the State of Washington and its communities have been harmed by
entities within the Pharmaceutical Supply Chain who manufacture, distribute, and dispense
prescription opioids;
Whereas, certain Local Governments, through their elected representatives and counsel,
are engaged in litigation seeking to hold these entities within the Pharmaceutical Supply Chain of
prescription opioids accountable for the damage they have caused to the Local Governments;
Whereas, Local Governments and elected officials share a common desire to abate and
alleviate the impacts of harms caused by these entities within the Pharmaceutical Supply Chain
throughout the State of Washington, and strive to ensure that principals of equity and equitable
service delivery are factors considered in the allocation and use of Opioid Funds; and
Whereas, certain Local Governments engaged in litigation and the other cities and counties
in Washington desire to agree on a form of allocation for Opioid Funds they receive from entities
within the Pharmaceutical Supply Chain.
Now therefore, the Local Governments enter into this Memorandum of Understanding
("MOU") relating to the allocation and use of the proceeds of Settlements described.
A. Definitions
As used in this MOU:
1. "Allocation Regions" are the same geographic areas as the existing
nine (9) Washington State Accountable Community of Health (ACH) Regions
and have the purpose described in Section C below.
2. "Approved Purpose(s)" shall mean the strategies specified and set
forth in the Opioid Abatement Strategies attached as Exhibit A.
3. "Effective Date" shall mean the date on which a court of
competent jurisdiction enters the first Settlement by order or consent decree. The
Parties anticipate that more than one Settlement will be administered according to
the terms of this MOU, but that the first entered Settlement will trigger allocation
of Opioid Funds in accordance with Section B herein, and the formation of the
Opioid Abatement Councils in Section C.
4. "Litigating Local Government(s)" shall mean Local Governments
that filed suit against any Pharmaceutical Supply Chain Participant pertaining to
the Opioid epidemic priorto September 1,2020.
L
5. "Local Government(s)" shall mean all counties, cities, and towns
within the geographic boundaries of the State of Washington.
6. 'National Settlement Agreements" means the national opioid
settlement agreements dated July 21,2021involving Johnson & Johnson, and
distributors AmerisourceBergen, Cardinal Health and McKesson as well as their
subsidiaries, affiliates, officers, and directors named in the National Settlement
Agreements, including all amendments thereto.
7. "Opioid Funds" shall mean monetary amounts obtained through a
Settlement as defined in this MOU.
8. "Opioid Abatement Council" shall have the meaning described in
Section C below.
9. "Participating Local Government(s)" shall mean all counties,
cities, and towns within the geographic boundaries of the State that have chosen
to sign on to this MOU. The Participating Local Governments may be referred to
separately in this MOU as "Participating Counties" and "Participating Cities and
Towns" (or "Participating Cities or Towns," as appropriate) or "Parties."
10. "Pharmaceutical Supply Chain" shall mean the process and
channels through which controlled substances are manufactured, marketed,
promoted, distributed, and/or dispensed, including prescription opioids.
11. "Pharmaceutical Supply Chain Participant" shall mean any entity
that engages in or has engaged in the manufacture, marketing, promotion,
distribution, andlor dispensing of a prescription opioid, including any entity that
has assisted in any ofthe above.
12. "Qualified Settlement Fund Account," or "QSF Account," shall
mean an account set up as a qualified settlement fund, 468b fund, as authorized by
Treasury Regulations 1.a68B-1(c) (26 CFR $1.4688-l).
13. "Regional Agreements" shall mean the understanding reached by
the Participating Local Counties and Cities within an Allocation Region
governing the allocation, management, distribution of Opioid Funds within that
Allocation Region.
14. "Settlement" shall mean the future negotiated resolution of legal or
equitable claims against a Pharmaceutical Supply Chain Participant when that
resolution has been jointly entered into by the Participating Local
Governments. "Settlement" expressly does not include a plan of reorganization
confirmed under Title 11of the United States Code, irrespective of the extent to
which Participating Local Governments vote in favor of or otherwise support such
plan of reorganization.
2
15. "Trustee" shall mean an independent trustee who shall be
responsible for the ministerial task of releasing Opioid Funds from a QSF account
to Participating Local Governments as authorized herein and accounting for all
payments into or out of the trust.
16. The "Washington State Accountable Communities of Health" or
((ACH" shall mean the nine (9) regions described in Section C below.
B. Allocation of Settlement Proceeds for Approved Purposes
1. All Opioid Funds shall be held in a QSF and distributed by the
Trustee, for the benefit of the Participating Local Governments, only in a manner
consistent with this MOU. Distribution of Opioid Funds will be subject to the
mechanisms for auditing and reporting set forth below to provide public
accountability and transparency.
2- All Opioid Funds, regardless of allocation, shall be utilized
pursuant to Approved Purposes as defined herein and set forth in Exhibit A.
Compliance with this requirement shall be verified through reporting, as set out in
this MOU.
3. The division of Opioid Funds shall first be allocated to
Participating Counties based on the methodology utilized for the Negotiation
Class in In Re: National Prescription Opiate Litigation, United States District
Court for the Northern Dishict of Ohio, Case No. l:17-md-02804-DAP. The
allocation model uses three equally weighted factors: (1) the amount of opioids
shipped to the county; (2) the number of opioid deaths that occurred in that
county; and (3) the number of people who suffer opioid use disorder in that
county. The allocation percentages that result from application of this
methodology are set forth in the "County Total" line item in Exhibit B. In the
event any county does not participate in this MOU, that county's percentage share
shall be reallocated proportionally amongst the Participating Counties by applying
this same methodology to only the Participating Counties.
4. Allocation and distribution of Opioid Funds within each
Participating County will be based on regional agreements as described in
Section C.
C. Regional Agreements
l. For the purpose of this MOU, the regional structure for decision-
making related to opioid fund allocation will be based upon the nine (9) pre-
defined Washington State Accountable Community of Health Regions (Allocation
Regions). Reference to these pre-defined regions is solely for the purpose of
3
a
a
a
a
a
a
a
drawing geographic boundaries to facilitate regional agreements for use of Opioid
Funds. The Allocation Regions are as follows:
King County (Single County Region)
Pierce County (Single County Region)
Olympic Community of Health Region (Clallam, Jefferson, and Kitsap
Counties)
C'ascade Pacific Action Alliance Region (Cowlitz, Grays Harbor, Lewis,
Mason, Pacific, Thurston, and Wahkiakum Counties)
North Sound Region (Island, San Juan, Skagit, Snohomish, and Whatcom
Counties)
SouthWest Region (Clark, Klickitat, and Skamania Counties)
Greater Columbia Region (Asotin, Benton, Columbia, Franklin, Garfield,
Kittitas, Walla Walla, Whitman, and Yakima Counties)
Spokane Region (Adams, Ferry, Lincoln, Pend Oreille, Spokane, and
Stevens Counties)
North Central Region (Chelan, Douglas, Grant, and Okanogan Counties)
2. Opioid Funds will be allocated, distributed and managed within
each Allocation Region, as determined by its Regional Agreement as set forth
below. If an Allocation Region does not have a Regional Agreement enumerated
in this MOU, and does not subsequently adopt a Regional Agreement per Section
C.5, the default mechanism for allocation, distribution and management of Opioid
Funds described in Section C.4.a will apply. Each Allocation Region must have
an OAC whose composition and responsibilities shall be defined by Regional
Agreement or as set forth in Section C.4.
3. King County's Regional Agreement is reflected in Exhibit C to this
MOU
4. All other Allocation Regions that have not specified a Regional
Agreement for allocating, distributing and managing Opioid Funds, will apply
the following default methodology:
a. Opioid Funds shall be allocated within each Allocation Region by
taking the allocation for a Participating County from Exhibit B and
apportioning those funds between that Participating County and its
Participating Cities and Towns. Exhibit B also sets forth the allocation to
the Participating Counties and the Participating Cities or Towns within the
Counties based on a default allocation formula. As set forth above in
Section B.3, to determine the allocation to a county, this formula utilizes:
(l) the amount of opioids shipped to the county; (2) the number of opioid
deaths that occurred in that county; and (3) the number of people who
suffer opioid use disorder in that county. To determine the allocation
within a county, the formula utilizes historical federal data showing how
the specific Counties and the Cities and Towns within the Counties have
4
made opioids epidemic-related expenditures in the past. This is the same
methodology used in the National Settlement Agreements for county and
intra-county allocations. A Participating County, and the Cities and Towns
within it may enter into a separate intra-county allocation agreement to
modiff how the Opioid Funds are allocated amongst themselves, provided
the modification is in writing and agreed to by all Participating Local
Governments in the County. Such an agreement shall not modifu any of
the other terms or requirements of this MOU.
b. 10% of the Opioid Funds received by the Region will be reserved,
on an annual basis, for administrative costs related to the OAC. The OAC
will provide an annual accounting for actual costs and any reserved funds
that exceed actual costs will be reallocated to Participating Local
Governments within the Region.
c. Cities and towns with a population of less than 10,000 shall be
excluded from the allocation, with the exception of cities and towns that
are Litigating Participating Local Governments. The portion of the Opioid
Funds that would have been allocated to a city or town with a population
of less than 10,000 that is not a Litigating Participating Local Government
shall be redistributed to Participating Counties in the manner directed
inC.4.a above.
d. Each Participating County, City, or Town may elect to have its
share re-allocated to the OAC in which it is located. The OAC will then
utilize this share for the benefit of Participating Local Governments within
that Allocation Region, consistent with the Approved Purposes set forth in
Exhibit A. A Participating Local Government's election to forego its
allocation of Opioid Funds shall apply to all future allocations unless the
Participating Local Government notifies its respective OAC otherwise. If a
Participating Local Government elects to forego its allocation of the
Opioid Funds, the Participating Local Government shall be excused from
the reporting requirements set forth in this Agreement.
e. Participating Local Governments that receive a direct
payment maintain full discretion over the use and distribution of their
allocation of Opioid Funds, provided the Opioid Funds are used solely for
Approved Purposes. Reasonable administrative costs for a Participating
Local Government to administer its allocation of Opioid Funds shall not
exceed actual costs or 10% of the Participating Local Government's
allocation of Opioid Funds, whichever is less.
f. A Local Government that chooses not to become a Participating
Local Government will not receive a direct allocation of Opioid Funds.
The portion of the Opioid Funds that would have been allocated to a Local
Government that is not a Participating Local Government shall be
5
redistributed to Participating Counties in the manner directed
inC.4.a above.
g. As a condition of receiving a direct payment, each Participating
Local Government that receives a direct payment agrees to undertake the
following actions:
i. Developing a methodology for obtaining proposals for use
of Opioid Funds.
ii. Ensuring there is opportunity for community-based input
on priorities for Opioid Fund programs and services.
iii. Receiving and reviewing proposals for use of Opioid Funds
for Approved Purposes.
iv. Approving or denying proposals for use of Opioid
Funds for Approved Purposes.
v. Receiving funds from the Trustee for approved proposals
and distributing the Opioid Funds to the recipient.
vi. Reporting to the OAC and making publicly available all
decisions on Opioid Fund allocation applications,
distributions and expenditures.
h. Prior to any distribution of Opioid Funds within the Allocation
Region, The Participating Local Governments must establish an Opioid
Abatement Council (OAC) to oversee Opioid Fund allocation,
distribution, expenditures and dispute resolution. The OAC may be a
preexisting regional body or may be a new body created for purposes of
executing the obligations of this MOU.
i. The OAC for each Allocation Region shall be composed of
representation from both Participating Counties and Participating Towns
or Cities within the Region. The method of selecting members, and the
terms for which they will serve will be determined by the Allocation
Region's Participating Local Governments. All persons who serve on the
OAC must have work or educational experience pertaining to one or more
Approved Uses.
j. The Regional OAC will be responsible for the following actions:
Overseeing distribution of Opioid Funds from Participating
Local Governments to programs and services within the
Allocation Region for Approved Purposes.
l.
6
Annual review of expenditure reports from
Participating Local Jurisdictions within the Allocation
Region for compliance with Approved Purposes and the
terms of this MOU and any Settlement.
ul In the case where Participating Local Governments chose
to forego their allocation of Opioid Funds:
(i) Approving or denying proposals by Participating Local
Governments or community groups to the OAC for use of
Opioid Funds within the Allocation Region.
(ii) Directing the Trustee to distribute Opioid Funds for use
by Participating Local Governments or community groups
whose proposals are approved by the OAC.
(iii) Administrating and maintaining records of all OAC
decisions and distributions of Opioid Funds.
IV Reporting and making publicly available all decisions on
Opioid Fund allocation applications, distributions and
expenditures by the OAC or directly by Participating Local
Governments.
V Developing and maintaining a centralized public dashboard
or other repository for the publication of expenditure data
from any Participating Local Government that receives
Opioid Funds, and for expenditures by the OAC in that
Allocation Region, which it shall update at least annually.
vl.If necessary, requiring and collecting additional outcome-
related data from Participating Local Governments to
evaluate the use of Opioid Funds, and all Participating
Local Governments shall comply with such requirements.
vll.Hearing complaints by Participating Local Governments
within the Allocation Region regarding alleged failure to
(l) use Opioid Funds for Approved Purposes or (2) comply
with reporting requirements.
5. Participating Local Governments may agree and elect to share,
pool, or collaborate with their respective allocation of Opioid Funds in any
manner they choose by adopting a Regional Agreement, so long as such
sharing, pooling, or collaboration is used for Approved Purposes and
complies with the terms of this MOU and any Settlement.
lt.
7
6. Nothing in this MOU should alter or change any Participating
Local Government's rights to pursue its own claim. Rather, the intent of
this MOU is to join all parties who wish to be Participating Local
Governments to agree upon an allocation formula for any Opioid Funds
from any future binding Settlement with one or more Pharmaceutical
Supply Chain Participants for all Local Governments in the State of
Washington.
7. If any Participating Local Government disputes the amount it
receives from its allocation of Opioid Funds, the Participating Local
Government shall alert its respective OAC within sixty (60) days of
discovering the information underlying the dispute. Failure to alert its
OAC within this time frame shall not constitute awaiver of the
Participating Local Government's right to seek recoupment of any
deficiency in its allocation of Opioid Funds.
8. If any OAC concludes that a Participating Local Government's
expenditure of its allocation of Opioid Funds did not comply with the
Approved Purposes listed in Exhibit A, or the terms of this MOU, or that
the Participating Local Government otherwise misused its allocation of
Opioid Funds, the OAC may take remedial action against the alleged
offending Participating Local Government. Such remedial action is left to
the discretion of the OAC and may include withholding future Opioid
Funds owed to the offending Participating Local Government or requiring
the offending Participating Local Government to reimburse improperly
expended Opioid Funds back to the OAC to be re-allocated to the
remaining Participating Local Governments within that Region.
9. All Participating Local Governments and OAC shall maintain all
records related to the receipt and expenditure of Opioid Funds for no less
than five (5) years and shall make such records available for review by
any other Participating Local Government or OAC, or the public. Records
requested by the public shall be produced in accordance with
Washington's Public Records Act RCW 42.56.001 et seq. Records
requested by another Participating Local Government or an OAC shall be
produced within twenty-one (21) days of the date the record request was
received. This requirement does not supplant any Participating Local
Government or OAC's obligations under Washington's Public Records
Act RCW 42.56.00I et seq.
D. Payment of Counsel and Litigation Expenses
1. The Litigating Local Governments have incurred attorneys' fees
and litigation expenses relating to their prosecution of claims against the
Pharmaceutical Supply Chain Participants, and this prosecution has inured to the
benefit of all Participating Local Governments. Accordingly, a Washington
8
Government Fee Fund ("GFF") shall be established that ensures that all Parties
that receive Opioid Funds contribute to the payment of fees and expenses incurred
to prosecute the claims against the Pharmaceutical Supply Chain Participants,
regardless of whether they are litigating or non-litigating entities.
2. The amount of the GFF shall be based as follows: the funds to be
deposited in the GFF shall be equal to l5o/o of the total cash value of the Opioid
Funds.
3. The maximum percentage of any contingency fee agreement
permitted for compensation shall be 15% of the portion of the Opioid Funds
allocated to the Litigating Local Government that is aparty to the contingency fee
agreement, plus expenses attributable to that Litigating Local Government. Under
no circumstances may counsel collect more for its work on behalf of a Litigating
Local Government than it would under its contingency agreement with that
Litigating Local Government.
4. Payments from the GFF shall be overseen by a committee (the
"Opioid Fee and Expense Committee") consisting of one representative of the
following law firms: (a) Keller Rohrback L.LP.; (b) Hagens Berman Sobol
Shapiro LLP; (c) Goldfarb & Huck Roth Riojas, PLLC; and (d) Napoli Shkolnik
PLLC. The role of the Opioid Fee and Expense Committee shall be limited to
ensuring that the GFF is administered in accordance with this Section.
5. In the event that seffling Pharmaceutical Supply Chain Participants
do not pay the fees and expenses of the Participating Local Governments directly
at the time settlement is achieved, payments to counsel for Panicipating Local
Governments shall be made from the GFF over not more than three years, with
50%paidwithin l2 months of the date of Settlement and25o/o paid in each
subsequent year, or at the time the total Sefflement amount is paid to the Trustee
by the Defendants, whichever is sooner.
6. Any funds remaining in the GFF in excess of: (i) the amounts
needed to cover Litigating Local Governments' private counsel's representation
agreements, and (ii) the amounts needed to cover the common benefit tax
discussed in Section C.8 below (if not paid directly by the Defendants in
connection with future settlement(s), shall revert to the Participating Local
Governments pro rata according to the percentages set forth in Exhibits B, to be
used for Approved Purposes as set forth herein and in Exhibit A.
7. In the event that funds in the GFF are not suffrcient to pay all fees
and expenses owed under this Section, payments to counsel for all Litigating
Local Governments shall be reduced on apro ratabasis. The Litigating Local
Governments will not be responsible for any of these reduced amounts.
9
8. The Parties anticipate that any Opioid Funds they receive will be
subject to a common benefit "tax" imposed by the court in In Re: National
Prescription Opiate Litigation, United States District Court for the Northern
District of Ohio, Case No. l:17-md-02804-DAP ("Common Benefit Tax"). If this
occurs, the Participating Local Governments shall first seek to have the settling
defendants pay the Common Benefit Tax. If the settling defendants do not agree
to pay the Common Benefit Tax, then the Common Benefit Tax shall be paid
from the Opioid Funds and by both litigating and non-litigating Local
Governments. This payment shall occur prior to allocation and distribution of
funds to the Participating Local Governments. In the event that GFF is not fully
exhausted to pay the Litigating Local Governments' private counsel's
representation agreements, excess funds in the GFF shall be applied to pay the
Common Benefit Tax (if any).
E. General Terms
l. If any Participating Local Government believes another
Participating Local Government, not including the Regional Abatement Advisory
Councils, violated the terms of this MOU, the alleging Participating Local
Government may seek to enforce the terms of this MOU in the court in which any
applicable Settlement(s) was entered, provided the alleging Participating Local
Government first provides the alleged offending Participating Local Government
notice of the alleged violation(s) and a reasonable opportunity to cure the alleged
violation(s). In such an enforcement action, any alleging Participating Local
Government or alleged offending Participating Local Government may be
represented by their respective public entity in accordance with Washington law.
2. Nothing in this MOU shall be interpreted to waive the right of any
Participating Local Government to seek judicial relief for conduct occurring
outside the scope of this MOU that violates any Washington law. In such an
action, the alleged offending Participating Local Government, including the
Regional Abatement Advisory Councils, may be represented by their respective
public entities in accordance with Washington law. In the event of a conflict, ffi!
Participating Local Government, including the Regional Abatement Advisory
Councils and its Members, may seek outside representation to defend itself
against such an action.
3. Venue for any legal action related to this MOU shall be in the
court in which the Participating Local Government is located or in accordance
with the court rules on venue in that jurisdiction. This provision is not intended to
expand the court rules on venue.
4. This MOU may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which shall constitute one and the
same instrument. The Participating Local Governments approve the use of
electronic signatures for execution of this MOU. All use of electronic signatures
10
shall be governed by the Uniform Electronic Transactions Act. The Parties agree
not to deny the legal effect or enforceability of the MOU solely because it is in
electronic form or because an electronic record was used in its formation. The
Participating Local Government agree not to object to the admissibility of the
MOU in the form of an electronic record, or a paper copy of an electronic
document, or a paper copy of a document bearing an electronic signature, on
the grounds that it is an electronic record or electronic signature or that it is not in
its original form or is not an original.
5. Each Participating Local Government represents that all
procedures necessary to authorize such Participating Local Government's
execution of this MOU have been performed and that the person signing for such
Party has been authorizedto execute the MOU.
[Remainder of Page Intentionally Left Blank- Signature Pages Follow]
11
This One Washington Memorandum of Understanding Between Washington
Municipalities is signed this _ day of 2022byz
Name & Title
On behalf of
4894-0031-1574, v. 2
L2
t!
XETt{
-EU
-Fi
OPIOID ABATEMENT STRATEGIES
PART ONE: TREATMENT
A. TREAT OPIOID USE DISORDER (OUD)
Support freatment of Opioid Use Disorder (OUD) and any co-occurring Substance Use
Disorder or Mental Health (SUDA4H) conditions, co-usage, and/or co-addiction through
evidence-based, evidence-informed, or promising programs or strategies that may include,
but are not limited to, the following:
l. Expand availability of treatment for OUD and any co-occurring SUDAvIH conditions,
co-usage, and/or co-addiction, including all forms of Medication-Assisted Treatment
(MAT) approved by the U.S. Food and Drug Administration.
2. Support and reimburse services that include the full American Society of Addiction
Medicine (ASAM) continuum of care for OUD and any co-occurring SUD/IVIH
conditions, co-usage, and/or co-addiction, including but not limited to:
a. Medication-Assisted Treatment (MAT);
b. Abstinence-based treatment;
c. Treatment, recovery, or other services provided by states, subdivisions,
community health centers; non-for-profit providers; or for-profit providers;
d. Treatment by providers that focus on OUD treatment as well as treatment by
providers that offer OUD treatment along with treatment for other SUDAVIH
conditions, co-usage, and/or co-addiction; or
e. Evidence-informed residential services programs, as noted below.
3. Expand telehealth to increase access to treatment for OUD and any co-occurring
SUD/IVIH conditions, co-usage, and/or co-addiction, including MAT, as well as
counseling, psychiatric support, and other treatment and recovery support services.
4. Improve oversight of Opioid Treatment Programs (OTPs) to assure evidence-based,
evidence-informed, or promising practices such as adequate methadone dosing.
5. Support mobile intervention, treatment, and recovery services, offered by qualified
professionals and service providers, such as peer recovery coaches, for persons with
OUD and any co-occuning SUD/\4H conditions, co-usage, and/or co-addiction and
for persons who have experienced an opioid overdose.
6. Support treatment of mental health trauma resulting from the traumatic experiences of
the opioid user (e.g., violence, sexual assault, human trafficking, or adverse childhood
experiences) and family members (e.g., surviving family members after an overdose
I
or overdose fatality), and training ofhealth care personnel to identifi and address such
trauma.
7. Support detoxification (detox) and withdrawal management services for persons with
OUD and any co-occurring SUD/MH conditions, co-usage, andlor co-addiction,
including medical detox, referral to treatment, or connections to other services or
supports.
8. Support training on MAT for health care providers, students, or other supporting
professionals, such as peer recovery coaches or recovery outreach specialists,
including telementoring to assist community-based providers in rural or underserved
areas.
9. Support workforce development for addiction professionals who work with persons
with OUD and any co-occurring SUDAvIH conditions, co-usage, and/or co-addiction.
10. Provide fellowships for addiction medicine specialists for direct patient care,
instructors, and clinical research for treatments.
I l. Provide funding and training for clinicians to obtain a waiver under the federal Drug
Addiction Treatment Act of 2000 (DATA 2000) to prescribe MAT for OUD, and
provide technical assistance and professional support to clinicians who have obtained
a DATA 2000 waiver.
12. Support the dissemination of web-based training curricula, such as the American
Academy of Addiction Psychiatry's hovider Clinical Support Service-Opioids web-
based training curriculum and motivational interviewing.
13. Support the development and dissemination of new curricula, such as the American
Academy of Addiction Psychiatry's Provider Clinical Support Service for
Medication-Assi sted Treatment.
B. SUPPORT PEOPLE IN TREATMENT AI\D RECOVERY
Support people in treatment for and recovery from OUD and any co-occurring SUDAvIH
conditions, co-usage, and/or co-addiction through evidence-based, evidence-informed, or
promising programs or strategies that may include, but are not limited to, the following:
1. Provide the full continuum of care of recovery services for OUD and any co-occurring
SUDA4H conditions, co-usage, and/or co-addiction, including supportive housing,
residential treatment, medical detox services, peer support services and counseling,
community navigators, case management, and connections to community-based
servlces.
2. Provide counseling, peer-support, recovery case management and residential
treatment with access to medications for those who need it to persons with OUD and
any co-occurring SUD/\4H conditions, co-usage, and/or co-addiction.
2
3. Provide access to housing for people with OUD and any co-occurring SUD/IVIH
conditions, co-usage, and/or co-addiction, including supportive housing, recovery
housing, housing assistance programs, or training for housing providers.
4. Provide community support services, including social and legal services, to assist in
deinstitutionalizingpersons with OUD and any co-occurring SUD/1\4H conditions, co-
usage, andl or co-addiction.
5. Support or expand peer-recovery centers, which may include support groups, social
events, computer access, or other services for persons with OUD and any co-occurring
SUDA4H conditions, co-usage, and/or co-addiction.
6. Provide employment training or educational services for persons in treatment for or
recovery from OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-
addiction.
7. Identifu successful recovery programs such as physician, pilot, and college recovery
programs, and provide support and technical assistance to increase the number and
capacity of high-quality programs to help those in recovery.
8. Engage non-profits, faith-based communities, and community coalitions to support
people in treatment and recovery and to support family members in their efforts to
manage the opioid user in the family.
9. Provide training and development of procedures for government staff to appropriately
interact and provide social and other services to current and recovering opioid users,
including reducing stigma.
10. Support stigma reduction efforts regarding treatment and support for persons with
OUD, including reducing the stigma on effective treatment.
C. CONI\'ECT PEOPLE WHO I\EBD HELP TO THE HELP THEY NEEI)
(CONI\ECTIONS TOCARE)
Provide connections to care for people who have - or are at risk of developing - OUD and
any co-occurring SUDA{H conditions, co-usage, and/or co-addiction through evidence-
based, evidence-informed, or promising programs or strategies that may include, but are not
limited to, the following:
1. Ensure that health care providers are screening for OUD and other risk factors and
know how to appropriately counsel and treat (or refer if necessary) a patient for OUD
treatment.
2- Support Screening, Brief Intervention and Referral to Treatment (SBIRT) programs to
reduce the transition from use to disorders.
3. Provide training and long-term implementation of SBIRT in key systems (health,
schools, colleges, criminal justice, and probation), with a focus on youth and young
adults when transition from misuse to opioid disorder is common.
J
4. Purchase automated versions of SBIRT and support ongoing costs of the technology.
5. Support training for emergency room personnel treating opioid overdose patients on
post-discharge planning, including community referrals for MAT, recovery case
management or support services.
6. Support hospital programs that transition persons with OUD and any co-occurring
SUDA4H conditions, co-usage, and/or co-addiction, or persons who have experienced
an opioid overdose, into community treatment or recovery services through a bridge
clinic or similar approach.
7. Support crisis stabilization centers that serve as an alternative to hospital emergency
departments for persons with OUD and any co-occurring SUDA4H conditions, co-
usage, and/or co-addiction or persons that have experienced an opioid overdose.
8. Support the work of Emergency Medical Systems, including peer support specialists,
to connect individuals to treatment or other appropriate services following an opioid
overdose or other opioid-related adverse event.
9. Provide funding for peer support specialists or recovery coaches in emergency
departments, detox facilities, recovery centers, recovery housing, or similar settings;
offer services, supports, or connections to care to persons with OUD and any co-
occurring SUDA4H conditions, co-usage, and/or co-addiction or to persons who have
experienced an opioid overdose.
10. Provide funding for peer navigators, recovery coaches, care coordinators, or care
managers that offer assistance to persons with OUD and any co-occurring SUD/VIH
conditions, co-usage, and/or co-addiction or to persons who have experienced on
opioid overdose.
I l. Create or support school-based contacts that parents can engage with to seek
immediate treatment services for their child; and support prevention, intervention,
treatment, and recovery programs focused on young people.
12. Develop and support best practices on addressing OUD in the workplace.
13. Support assistance programs for health care providers with OUD.
14. Engage non-profits and the faith community as a system to support outreach for
treatment.
15. Support centralized call centers that provide information and connections to
appropriate services and supports for persons with OUD and any co-occurring
SUDA{H conditions, co-usage, and/or co-addiction.
16. Create or support intake and call centers to facilitate education and access to
treatment, prevention, and recovery services for persons with OUD and any co-
occurring SUDA4H conditions, co-usage, and/or co-addiction.
4
17. Develop or support a National Treatment Availability Clearinghouse a
multistate/nationally accessible database whereby health care providers can list
locations for currently available in-patient and out-patient OUD treatment services
that are accessible on a real-time basis by persons who seek treatment.
D.
Address the needs of persons with OUD and any co-occurring SUD/MH conditions, co-
usage, and/or co-addiction who are involved - or are at risk of becoming involved - in the
criminal justice system through evidence-based, evidence-informed, or promising programs
or strategies that may include, but are not limited to, the following:
1. Support pre-arrest or post-arrest diversion and deflection strategies for persons with
OUD and any co-occurring SUDA4H conditions, co-usage, and/or co-addiction,
including established strategies such as:
a. Self-referral strategies such as the Angel Programs or the Police Assisted
Addiction Recovery lnitiative (PAARI);
b. Active outreach strategies such as the Drug Abuse Response Team (DART)
model;
c. 'Naloxone Plus" strategies, which work to ensure that individuals who have
received naloxone to reverse the effects of an overdose are then linked to
treatment programs or other appropriate services;
d. Officer prevention strategies, such as the Law Enforcement Assisted Diversion
(LEAD) model;
e. Officer intervention strategies such as the Leon County, Florida Adult Civil
Citation Network or the Chicago Westside Narcotics Diversion to Treatment
Initiative;
f. Co-responder andlor alternative responder models to address OUD-related 911
calls with greater SUD expertise and to reduce perceived barriers associated with
law enforcement 911 responses; or
g. County prosecution diversion programs, including diversion officer salary, only
for counties with a population of 50,000 or less. Any diversion services in matters
involving opioids must include drug testing, monitoring, or treatment.
2. Support pre-trial services that connect individuals with OUD and any co-occurring
SUDA{H conditions, co-usage, and/or co-addiction to evidence-informed treatment,
including MAT, and related services.
3. Support treatment and recovery courts for persons with OUD and any co-occurring
SUDA/IH conditions, co-usage, and/or co-addiction, but only if these courts provide
referral s to evidence-informed treatment, includin g MAT.
5
4. Provide evidence-informed treatment, including MAT, recovery support, or other
appropriate services to individuals with OUD and any co-occurring SUDA{H
conditions, co-usage, and/or co-addiction who are incarcerated in jail or prison.
5. Provide evidence-informed treatment, including MAT, recovery support, or other
appropriate services to individuals with OUD and any co-occurring SUDA4H
conditions, co-usage, andlor co-addiction who are leaving jail or prison have recently
left jail or prison, are on probation or parole, are under community corrections
supervision, or are in re-entry programs or facilities.
6. Support critical time interventions (CTI), particularly for individuals living with dual-
diagnosis OUD/serious mental illness, and services for individuals who face
immediate risks and service needs and risks upon release from correctional settings.
7. Provide training on best practices for addressing the needs of criminal-justice-
involved persons with OUD and any co-occurring SUDIN4H conditions, co-usage,
andlor co-addiction to law enforcement, correctional, or judicial personnel or to
providers of treatment, recovery, case management, or other services offered in
connection with any of the strategies described in this section.
E. ADDRESS THE I\"EEDS OF PREGNANT OR PARENTING WOMEN AND
THEIR FAMILIES. INCLUDING BABIES WITH NEONATAL ABSTINENCE
SYNDROME
Address the needs of pregnant or parenting women with OUD and any co-occurring
SUDA4H conditions, co-usage, and/or co-addiction, and the needs of their families, including
babies with neonatal abstinence syndrome, through evidence-based, evidence-informed, or
promising programs or strategies that may include, but are not limited to, the following:
l. Support evidence-based, evidence-informed, or promising treatment, including MAT,
recovery services and supports, and prevention services for pregnant women - or
women who could become pregnant - who have OUD and any co-occurring SUD/\4H
conditions, co-usage, and/or co-addiction, and other measures to educate and provide
support to families affected by Neonatal Abstinence Syndrome.
2. Provide training for obstetricians or other healthcare personnel that work with
pregnant women and their families regarding treatment of OUD and any co-occurring
SUD/\4H conditions, co-usage, and/or co-addiction.
3. Provide training to health care providers who work with pregnant or parenting women
on best practices for compliance with federal requirements that children born with
Neonatal Abstinence Syndrome get referred to appropriate services and receive a plan
ofsafe care.
4. Provide enhanced support for children and family members suffering trauma as a
result of addiction in the family; and offer trauma-informed behavioral health
treatment for adverse childhood events.
6
F'
5. Offer enhanced family supports and home-based wrap-around services to persons with
OUD and any co-occurring SUDA{H conditions, co-usage, and/or co-addiction,
including but not limited to parent skills training.
6. Support for Children's Services - Fund additional positions and services, including
supportive housing and other residential services, relating to children being removed
from the home and./or placed in foster care due to custodial opioid use.
PART TWO: PREVENTION
PREVENT OVER.PRESCRIBING AND ENSURE APPROPRIATE
PRESCRIBING AIID DISPENSING OF OPIOIDS
Support efforts to prevent over-prescribing and ensure appropriate prescribing and dispensing
of opioids through evidence-based, evidence-informed, or promising programs or strategies
that may include, but are not limited to, the following:
1. Training for health care providers regarding safe and responsible opioid prescribing,
dosing, and tapering patients off opioids.
2. Academic counter-detailing to educate prescribers on appropriate opioid prescribing.
3. Continuing Medical Education (CME) on appropriate prescribing of opioids.
4. Support for non-opioid pain treatment alternatives, including training providers to
offer or refer to multi-modal, evidence-informed treatment of pain.
5. Support enhancements or improvements to Prescription Drug Monitoring Programs
(PDMPs), including but not limited to improvements that:
a. Increase the number of prescribers using PDMPs;
b. Improve point-of-care decision-making by increasing the quantity, quality, or
format of data available to prescribers using PDMPs or by improving the
interface that prescribers use to access PDMP data, or both; or
c. Enable states to use PDMP data in support of surveillance or intervention
strategies, including MAT referrals and follow-up for individuals identified
within PDMP data as likely to experience OUD.
6. Development and implementation of a national PDMP - Fund development of a
multistate/national PDMP that permits information sharing while providing
appropriate safeguards on sharing of private health information, including but not
limited to:
a. Integration of PDMP data with electronic health records, overdose episodes,
and decision support tools for health care providers relating to OUD.
7
b. Ensuring PDMPs incorporate available overdose/naloxone deployment data,
including the United States Department of Transportation's Emergency
Medical Technician overdose database.
7. Increase electronic prescribing to prevent diversion or forgery.
8. Educate Dispensers on appropriate opioid dispensing
G. PREVENT MISUSE OF' OPIOIDS
Support efforts to discourage or prevent misuse of opioids through evidence-based, evidence-
informed, or promising programs or strategies that may include, but are not limited to, the
following:
l. Corrective advertising or affirmative public education campaigns based on evidence.
2. Public education relating to drug disposal.
3. Drug take-back disposal or destruction programs.
4. Fund community anti-drug coalitions that engage in drug prevention efforts.
5. Support community coalitions in implementing evidence-informed prevention, such
as reduced social access and physical access, stigma reduction - including staffing,
educational campaigns, support for people in treatment or recovety, or training of
coalitions in evidence-informed implementation, including the Strategic Prevention
Framework developed by the U.S. Substance Abuse and Mental Health Services
Administration (SAMHSA).
6. Engage non-profits and faith-based communities as systems to support prevention.
7. Support evidence-informed school and community education programs and
campaigns for students, families, school employees, school athletic programs, parent-
teacher and student associations, and others.
8. School-based or youth-focused programs or strategies that have demonstrated
effectiveness in preventing drug misuse and seem likely to be effective in preventing
the uptake and use of opioids.
9. Support community-based education or intervention services for families, youth, and
adolescents at risk for OUD and any co-occurring SUD/MH conditions, co-usage,
and/or co-addiction.
10. Support evidence-informed programs or curricula to address mental health needs of
young people who may be at risk of misusing opioids or other drugs, including
emotional modulation and resilience skills.
ll.Support greater access to mental health services and supports for young people,
including services and supports provided by school nurses or other school staff, to
8
address mental health needs in young people that (when not properly addressed)
increase the risk of opioid or other drug misuse.
H. PREVENT OVERDOSE DEATHS AND OTHERHARMS
Support efforts to prevent or reduce overdose deaths or other opioid-related harms through
evidence-based, evidence-informed, or promising programs or strategies that may include,
but are not limited to, the following:
l. Increase availability and distribution of naloxone and other drugs that treat overdoses
for first responders, overdose patients, opioid users, families and friends of opioid
users, schools, community navigators and outreach workers, drug offenders upon
release from jail/prison, or other members of the general public.
2. Provision by public health entities of free naloxone to anyone in the community,
including but not limited to provision of intra-nasal naloxone in settings where other
options are not available or allowed.
3. Training and education regarding naloxone and other drugs that treat overdoses for
first responders, overdose patients, patients taking opioids, families, schools, and
other members of the general public.
4. Enable school nurses and other school staff to respond to opioid overdoses, and
provide them with naloxone, training, and support.
5. Expand, improve, or develop data tracking software and applications for
overdoses/naloxone revivals.
6. Public education relating to emergency responses to overdoses.
7. Public education relating to immunity and Good Samaritan laws.
8. Educate first responders regarding the existence and operation of immunity and Good
Samaritan laws.
9. Expand access to testing and treatment for infectious diseases such as HIV and
Hepatitis C resulting from inhavenous opioid use.
10. Support mobile units that offer or provide referrals to treatment, recovery supports,
health care, or other appropriate services to persons that use opioids or persons with
OUD and any co-occuning SUD/I\4H conditions, co-usage, and/or co-addiction.
ll.Provide training in treatment and recovery strategies to health care providers,
students, peer recovery coaches, recovery outreach specialists, or other professionals
that provide care to persons who use opioids or persons with OUD and any co-
occurring SUD/IVIH conditions, co-usage, and/or co-addiction.
12. Support screening for fentanyl in routine clinical toxicology testing.
9
PART THREE: OTHER STRATEGIES
I. FIRST RESPONDERS
In addition to items C8, Dl through D7,Hl, H3, and H8, support the following:
1. Current and future law enforcement expenditures relating to the opioid epidemic.
2. Educate law enforcement or other first responders regarding appropriate practices and
precautions when dealing with fentanyl or other drugs.
J. LEADERSHIP. PLANNING AI\D COORDINATION
Support efforts to provide leadership, planning, and coordination to abate the opioid epidemic
through activities, programs, or strategies that may include, but are not limited to, the
following:
1. Community regional planning to identifu goals for reducing harms related to the
opioid epidemic, to identify areas and populations with the greatest needs for
treatment intervention services, or to support other strategies to abate the opioid
epidemic described in this opioid abatement strategy list.
2. A government dashboard to track key opioid-related indicators and supports as
identified through collaborative community processes.
3. Invest in infrastructure or staffing at government or not-for-profit agencies to support
collaborative, cross-system coordination with the purpose of preventing
overprescribing, opioid misuse, or opioid overdoses, treating those with OUD and any
co-occurring SUDAvIH conditions, co-usage, and/or co-addiction, supporting them in
treatment or recovery, connecting them to care, or implementing other strategies to
abate the opioid epidemic described in this opioid abatement strategy list.
4. Provide resources to staff government oversight and management of opioid abatement
programs.
K. TRAINING
In addition to the training referred to in various items above, support training to abate the
opioid epidemic through activities, programs, or strategies that may include, but are not
limited to, the following:
l. Provide funding for staff training or networking programs and services to improve the
capability of government, community, and not-for-profit entities to abate the opioid
crlsls.
2. Invest in infrastructure and staffing for collaborative cross-system coordination to
prevent opioid misuse, prevent overdoses, and treat those with OUD and any co-
occurring SUDA4H conditions, co-usage, and/or co-addiction, or implement other
l0
strategies to abate the opioid epidemic described in this opioid abatement strategy list
(e.g., health care, primary care, pharmacies, PDMPs, etc.).
L. RESEARCH
Support opioid abatement research that may include, but is not limited to, the following:
1. Monitoring, surveillance, and evaluation of programs and strategies described in this
opioid abatement strategy list.
2. Research non-opioid treatment of chronic pain.
3. Research on improved service delivery for modalities such as SBIRT that demonstrate
promising but mixed results in populations vulnerable to opioid use disorders.
4. Research on innovative supply-side enforcement efforts such as improved detection of
mail-based delivery of synthetic opioids.
5. Expanded research on swift/certain/fafu models to reduce and deter opioid misuse
within criminal justice populations that build upon promising approaches used to
address other substances (e.g. Hawaii HOPE and Dakota 24/7).
6. Research on expanded modalities such as prescription methadone that can expand
access to MAT.
ll
EXHIBIT B
Adams Countv
Adams County
Asotin Countv
Asotin Cou
Asotin
Clarkston
Benton Countv
Benton County
Benton
Kennewick
Prosser
Richland
West Richland
Chelan Countv
Chelan County
Cashmere
Chelan
Entiat
Leavenworth
Wenatchee
County Total:
Clallam Countv
Clallam County
Forks
Port Angeles
Sequim
Hatton
Lind
othello
Ritzville
Washtucna
CountyTotal: 0.L638732475%
o.4694498386%
CountyTotal: 0.4694498386%
0.04s9360490%
County Total: 2.5480622463%
o.74349L4485%
0.7638732475%
r.484883t892%
0.5415550564%
0.4756779517%
0.2968333494%
L.0403247979%
7.307698340L%
o.4598370527%
countyTotal: t.7675353928%
*** - Local Government appears in multiple counties B-1
EXHIBIT B
Clark Countv
Clark County
Columbia Counw
Columbia County
Starbuck
Cowlitz CounW
Cowlitz County
Castle Rock
Kalama
Kelso
Woodland***
Douglas Countv
Douglas County
Bridgeport
Coulee Dam***
East Wenatchee
Mansfield
Rock lsland
Waterville
Ferry Countv
Ferry County
Republic
Battle Ground
Camas
La Center
Ridgefield
Vancouver
Washougal 0.
Woodland***
Yacolt
4.5t49775326%
0.1384729857%
0.2597592724%
L.7306605325%
1279328220%
Total: 6.78L2O3L452%
r.7226945990%
0.L33t!45270o/o
o.6t62736905%
0.3932t751750/o
0.0s6r699537%
CountyTotal: 0.0561699537%
counryTotal: 2.4720828165%
0.0799810865%
Total: O.473L98604O%
0.1753487994%
CountyTotal: 0.LL53487994%
*** - Local Government appears in multiple counties B-2
EXHIBIT B
f
Franklin Countv
Franklin County
Connell
Kahlotus
Mesa
Pasco
Garfield Countv
Garfield
Pomeroy
Grant CounW
Grant Cou
Coulee City
Coulee Dam***
Electric City
E hrata
George
Grand Coulee
Hartline
Krupp
Mattawa
Moses Lake
Qu
RoyalCity
Soa Lake
Warden
Wilson Creek
o.336L237L44%
0.42780s6066%
Total: 0.76392932tO%
0.O32L9822O9o/o
Total: 0.O32L982209%
0.9932572t67%
o.2078293909%
CountyTotal: 1.2010866076%
*** - Local Government appears in multiple counties B-3
EXHIBIT B
Gravs Harbor Countv
Grays Harbor County
Aberdeen
Cosmo ts
Elma
Hoquiam
McCleary
Montesano
Oakville
Ocean Shores
Westport
lsland CounW
lsland County
Coupeville
La
Oak Harbor
0.9992429t38%
O.249L525333o/o
CountyTotalz L.248395447L%
0.68204225L0o/o
o.2sLt55043L%
CountyTotal: 0.9331973O4I%
0.44t7L37380o/o
Total: 0.44L7L3738O%
Jefferson County
Jefferson
Port Townsend
*** - Local Government appears in multiple counties B-4
EXHIBIT B
Kins Countv
King County 73.9743722662%
Auburn***o.26227749L7%
Beaux Arts Village
Bellevue t.t300592573%
Black Diamond
Bothell***0.L8216027t6%
Burien o.o27096292t%
Carnation
Clyde Hill
Covington o.orL8L34406%
Des Moines 0.tL79764526%
Duvall
Enumclaw***0.0537768326%
FederalWay 0.3061452240%
Hunts Point
lssaquah 0.L875240t07%
Kenmore o.o20444LO24%
Kent 0.53773976760/o
Kirkland o.54535252460/o
Lake Forest Park 0.0s25439L24%
Maple Valley O.OO937615870/o
Medina
Mercer lsland 0.L75!79748L%
Milton***
Newcastle 0.0033117880%
Normandy Park
North Bend
Pacific***
Redmond 0.48394860070/o
Renton o.7652526920%
Sammamish 0.0224369090%
SeaTac 0.r48L557278%
Seattle 6.6O324038160/o
Shoreline 0.043s834501%
Skykomish
Snoqualmie 0.064916448t%
Tukwila O.30322O5739o/o
Woodinville 0.0185516364%
Yarrow Point
CountyTotal: 26.0505553608%
*** - LocalGovernment appears in multiple counties B-5
EXHIBIT B
ffi
Kitsap CounW
Kitsap County
Bainbridge lsland
Bremerton
Port Orchard
Poulsbo
County Total:
Kittitas Countv
Kittitas County
Cle Elum
Ellensburg
Kittitas
Roslyn
South Cle Elum
Klickitat Countv
Klickitat County
Bingen
Goldendale
White Salmon
Lewis CounW
Lewis Co
County Total: O.48t1529598%
2.6294t33668%
0.L3646860L4o/o
0.6L93374389o/o
0.7009497L62%
0.0773748246%
3.5635439479%
0.38s5704683%
o.0955824915%
o.227L673457%
Cou Total: 0.22L1673457%
L.0777377479o/o
Centralia 0.19099903s3%
Chehalis
Morton
lvl,r;fl(oql
Napavine
Pe Ell
Toledo
Vader
Winlock
CountyTotal: L.2687367832%
*** - Local Government appears in multiple counties 8-6
Lincoln CounW
Lincoln Cou
Almira
Creston
Davenport
Harrington
Odessa
Reardan
Sprague
Wilbur
Mason Countv
Mason Cou
Shelton
Okanosan Countv
Oka Cou
Brewster
Conconul
Coulee Dam***
Elmer
Nespelem
Okanogan
Omak
Oroville
Pateros
Riverside
Tonasket
Twisp
Winthrop
County Total:
EXHIBIT B
o.t7t2669645%
County Total:0.17L2669645%
o.80899r80L2%
O.L239L79888o/o
County Total: 0.9329097900%
0.6L45043345%
Pacific Countv
Pacific County
0.6L45043345%
o.48954L6466%
llwaco
Long Beach
!eyu_'rg -
South Bend
County Total: 0.4895475466%
*** - Local Government appears in multiple counties B-7
EXHIBIT B
Pend Oreille CounW
Pend Oreille County
Cusick
lone
Metaline
Metaline Falls
Newport
Pierce CounW
Pierce County
Auburn***
Bonney Lake
Buckley
Carbonado
DuPont
Eatonville
Edgewood
Enumclaw***
Fife
Fircrest
Gig Harbor
Lakewood
Milton***
Orting
Pacific***
Puyallup
Ruston
South Prairie
Steilacoom
Sumner
Tacoma
University Place
Wilkeson
San Juan Countv
San Juan County
F Harbor
CountyTotal: 0.2565374940%
7.2310L64020%
0.0628522tL2o/o
0.2s66374940%
0.tr90773864%
o.004801679L%
0.0000000000%
0.1955185481_%
0.0859963345%
o.52535408940/o
0384s7048r4%
O.7083L57569o/o
3.2816374617%
0.0353733363%
O.21O1495771o/o
County Total: t2.034523687 0%
countyTotal: o.2Lo7495t7I%
*** - Local Government appears in multiple counties B-8
EXHIBIT B
Skaeit Countv
Skagit County
Anacortes
lgdtlstgt
Concrete
Hamilton
La Conner
Lyman
Mount Vernon
Sedro-Woolley
Skamania Countv
Skamania Cou
North Bonneville
Stevenson
Snohomish Countv
Snohomish County
Arlington
Bothell** *
Brier
Darrington
Edmonds
Everett
Gold Bar
Granite Falls
lndex
Lake Stevens
Lynnwood
Marysville
MillCreek
Monroe
Mountlake Terrace
Mukilteo
Snohomish
Stanwood
Sultan
Woodway
County Totaf : 0.L63L93t925%
1.0s2602396L%
O.I7749629o60/o
o.tt4686L66t%
0.2801063665%
o.o66Lt4635t%
Total: L6910O58544%
o.163L93r925%
6.90544L5622%
0.2620524080%
0.25s4ss8588%
0.30s8936009%
1.925836324L%
0.I38520289Lo/o
O.77046292L4o/o
0.3945067827%
o.L227939546%
0.L77L627898%
0.210893s805%
O.256179O7O2o/o
o.o8610979640/o
County Total: tL.82L3083387%
*** - Local Government appears in multiple counties B-9
ffi
EXHIBIT B
Spokane Countv
Spokane County
Stevens CounW
Stevens County
Chewelah
Colville
Kettle Falls
Marcus
Northport
Springdale
Thurston Countv
Thurston County
Bucoda
Lacey
Olympia
Rainier
Tenino
Tumwater
Yelm
Wahkiakum Countv
Wahkiakum County
Cathlamet
5.5623859292%
Airway Heights
Cheney o.1238454349%
Deer Park
Fairfield
Latah
Liberty Lake 0.0389636519%
Medical Lake
Millwood
Rockford
Spangle
Spokane 3.0872078287%
lg"lg!gyg[9y*_ * 9.998!-?!7sooo/:
Waverly
Total: 8.8808245947%
O.747924OL79o/o
Total: 0.7479240t79%
2.32584920940/o
0.234862722to/o
O.60394233850/o
0.2065982350%
County Totaf : 3.371-2525050%
0.0596582L97o/o
CountyTotal: 0.0596582t97%
*** - Local Government appears in multiple counties B-10
EXHIBIT B
Walla Walla Countv
Walla Walla County
College Place
Prescott
Waitsburg
Walla Walla
Whatcom Countv
Whatcom Cou
Bell m
Blaine
Everson
Ferndale
den
Nooksack
Sumas
Whitman Countv
Whitman County
Albion
Colfax
Colton
Endicott
Farmington
Garfield
LaCrosse
Lamont
Malden
Oakesdale
Palouse
Pullman
Rosalia
St. John
Tekoa
Uniontown
o.s543870294%
L
0.3140768654%
County Total: 0.8684638948%
r.3452637306%
O.89786L4577o/o
O.O646tOL89to/o
o.0827LL56L2%
CountyTotal: 2.3904469386%
0.2626805837%
O.22t483749to/o
County Total: O.484L643328%
*** - Local Government appears in multiple counties B-11
EXHIBIT B
Yakima CounW
Yakima County
Grandview
Granger
Harrah
Mabton
Moxee
Naches
Selah
Sunnyside
Tieton
To nish
Union Ga
Wapato
Yakima
Zillah
L.93883929s9%
0.0530606109%
0.L2L3478384o/o
0.50604L0539%
County Total: 2.7L9288799Lo/o
*** - Local Government appears in multiple counties B-12
rn
Xl-r
-fl .dFi.+o
KING COUNTY REGIONAL AGREEMENT
King County intends to explore coordination with its cities and towns to facilitate a Regional
Agreement for Opioid Fund allocation. Should some cities and towns choose not to participate in
a Regional Agreement, this shall not preclude coordinated allocation for programs and services
between the County and those cities and towns who elect to pursue a Regional Agreement. As
contemplated in C.5 of the MOU, any Regional Agreement shall comply with the terms of the
MOU and any Settlement. If no Regional Agreement is achieved, the default methodology for
allocation in C.4 of the MOU shall apply.
EXHIBIT B
GREATER COLUMBIA OPIOID ABATEMENT COUNCIL MEMORANDIUM OF UNDERSTANDING
MEMORANDUM OF UNDERSTANDING BETWEEN THE GREATER COLUMBIA
REGION MUNICIPALITIES TO ESTABLISH AN OPIOID ABATEMENT COUNCIL
Whereas, the people of the State of Washington and its communities have been harmed by entities
within the Pharmaceutical Supply Chain who manufacture, distribute, and dispense prescription opioids;
Whereas, certain Local Governments, through their elected representatives and counsel are engaged in
litigation seeking to hold these entities within the Pharmaceutical Supply Chain of prescription opioids
accountable for the damage they have caused to the Local Governments;
Whereas, Local Governments and elected officials share a common desire to abate and alleviate the
impacts of harms caused by these entities within the Pharmaceutical Supply Chain throughout the State
of Washington, and strive to ensure that principals of equity and equitable service delivery are factors
considered in the allocation and use of Opioid Funds;
Whereas, Certain Local Governments engaged in litigation and the other cities and counties in
Washington desire to agree on a form of allocation for Opioid Funds they receive from entities within
the Pharmaceutical Supply Chain;
Whereas, Local Governments who receive funds that are governed by the August 2O22 One Washington
Memorandum of Understanding are required to participate in an Opioid Abatement Council to oversee
and approve the plans forthe spending of those funds;
Now therefore, the Local Governments within the Greater Columbia Region enter into this
Memorandum of Understanding ("MOU"! relating to the formation of an Opioid Abatement Council.
A. Definitions
As used in this MOU:
1. "Administering Agency" shall mean the Greater Columbia Behavioral Health, LLC.
2. "Approved Purposes" shall mean the strategies specified and set forth in the
Opioid Abatement Strategies attached as Exhibit A.
3. "Greater Columbia Region" shall mean the allocation region as determined by the
August 2022 Qne Washington Memorandum of Understanding between
Washington Mu nicipalities (One Washington MOU) made up of the following
counties: Asotin, Benton, Columbia, Franklin, Garfield, Kittitas, Walla Walla,
Whitman, and Yakima.
4- "Participating Local Governments" shall mean those local governments that have
chosen to sign on to the One Washington MOU. The Participating Local
Governments for this MOU are: Asotin County, Benton County, Columbia County,
Franklin County, Garfield County, Kittitas County, Walla Walla County, Whitman
County, Yakima County, Kennewick, Richland, West Richland, Pasco, Ellensburg,
Walla Walla, Pullman, Grandview, Sunnyside and Yakima,
5. "Opioid Abatement Council (OAC)" shall mean the group of representatives from
the municipalities receiving funds within the Greater Columbia Region to oversee
Opioid fund allocation, distribution, expenditures and dispute resolution as well as
other responsibilities laid out in this MOU. See also One Washington MOU.
6. "Opioid Funds" shall mean monetary amounts obtained through a Settlement as
defined in the One Washington MOU.
B. Opioid Abatement Council
a. All Parlicipating Local Governments may have one representative on the OAC
subject to the requirements detailed in the One Washington MOU..
b. The OAC shall meet on a quarterly basis or as needed, as determined by the
Administering Agenry.
c. All Participating Local Governments will submit a spending plan to the OAC that
complies with the Approved Purposes as outlined in Exhibit A, prior to the
Participating Local Governments' expenditure of any Opioid funds.
d. Responsibilities of the OAC:
i. Overseeing distribution of Opioid Funds from Participating Local
Governments to programs and services within the Allocation Region for
Approved Purposes.
ii. Annual review of expenditure reports from Participating Local
Jurisdictions within the Allocation Region for compliance with Approved
Purposes and the terms of this MoU and any Settlement. To facilitate this
process, each Participating Local Government shall submit monthly
expenditure reports for each month that funds were distributed.
iii. Reporting and making publicly available all decisions on Opioid Fund
allocation applications, distributions and expenditures by the OAC or
directly by Participating Local Governments.
iv. Developing and maintaining a centralized public dashboard or other
repository for the publication of expenditure data from any Participating
Local Government that receives Opioid Funds, and for expenditures by the
OAC in that Allocation Region, which it shall update at least annually.
v, Hearing complaints by Participating Local Governments within the
Allocation Region regardlng alleged failure to:
1. Use Opioid Funds for Approved Purposes or
2. Comply with reporting requirements.
vi. lf necessary, requiring and collecting additional outcome related data
from Participating Local Governments to evaluate the use of Opioid
Funds, and all Participating Local Governrnents shall comply with such
requirements.
e. lf the OAC concludes that a Participating Local Government's expenditure of its
allocation of Opioid Funds did not comply with the Approved Purposes listed in
Exhibit A or the terms of this MOU, or that the Participating Local Government
otherwise misused its allocation of Opioid Funds, the OAC may take remedial
action against the alleged offending Participating Local Government. Such
remedialaction is leftto the discretion of the OAC and may include withholding
future Opioid Funds owed to the offending Participating Local Government or
requiring the offending Participating Local Government to reimburse improperly
expended Opioid Funds back to the OAC to be re-allocated to the rernaining
Participating Local Governments within the Region.
f. All Participating Local Governments and the OAC shall maintain all records related
to the receipt and expenditure of Opioid Funds for no less than five (5) years and
shall make such records available for review by any other Participating Local
Government or OAC, or the public. Records requested by the public shall be
produced in accordance with Washington's Public Records Act RCW 42.56.00Iet
seq. Records requested by another Participating Local Government or an OAC
shall be produced within twenty-one (21) days of the date the record request was
received. This requirement does not supplant any Participating Local Government
or OAC's obligations under Washington s Public Records Act RCW 42.56-001 et
seq.
g. Each Participating Local Government may elect to have its share re-allocated to
the OAC. The OAC willthen utilize this share for the benefit of Participating Local
Governments within the Allocation Region, consistent with the Approved
Purposes set forth in Exhibit A. A Participating Local Government's election to
forego its allocation of Opioid Funds shall apply to all future allocations unless the
Participating local Government notifies the OAC otherwise. lf a Participating Local
Government elects to forego its allocation of the Opioid Funds, the Participating
Local Government shall be excused from the reporting requirements set forth in
this Agreement.
i. ln the case where Participating Local Governments chose to forego their
allocation of Opioid fund, the OAC shall be responsible for:
7. Approving or denying proposals by Participating Local
Governments or community groups to the OAC for use of Opioid
Funds within the Allocation Region.
2- Directing the Trustee to distribute Opioid Funds for use by
Participating Local Governments or community groups whose
proposals are approved by the OAC,
3. Administrating and maintaining records of all OAC decisions and
distributions of Opioid Funds.
h. Participating Local Governments will reserve 10% of the Opioid Funds received for
administrative costs related to the OAC. The OAC will provide an annual
accounting for actual costs, and any remaining funds may then be used for the
Participating Local Government's Approved purpose. The Administering Agency
will be responsible for providing staffing and administrative support for the OAC.
MEMORANDUM OF UNDERSTANDING BETWEEN THE GREATER COLUMBIA
REGION MUNICIPALITIES TO ESTABLISH AN OPIOID ABATEMENT COUNCIL
This Memorandum of Understandine between the Greater
an opioid Abatement council is signlu tnis Iw day of
bia Region Municipalities to Establish
2O23by:
Name &
On Behalf of
Exhibit A
OPIOID ABATEMENT STRATEGIES
Participating Local Governments that receive a direct payment maintain full
discretion over the use and distribution of their allocation of Opioid Funds,
provided the Opioid Funds are used solely for Approved Purposes. Reasonable
administrative costs for a Participating Local Government to administer its
allocation of Opioid Funds shall not exceed actual costs or 10% of the
Participating Local Government's allocation Opioid Funds, whichever is less.
PART ONE: TREATMENT
A. TREAT OPIOID USE DISORDER {OUDI
Support treatment of Opioid Use Disorder (OUD) and any co-occurring Substance Use
Disorder or Mental Health (SUD/MH) conditions. Co-usage, and/or co-addiction through
evidence-based, evidence-informed, or promising programs or strategies that may include,
but are not limited to, the following:
1. Expand availability of treatment for OUD and any co-occurring SUD/MH conditions,
co-usage, andlor co-addiction. lncluding all forms of Medication-Assisted Treatment
{MAT) approved by the U.S. Food and Drug Administration.
2. Support and reimburse services that include the full American Society of Addiction
Medicine (ASAM) continuum of care for OUD and any co-occurring SUD/MH
conditions, co-usage, and/or co-addiction, including but not limited to:
a. Medication-Assisted Treatment (MAT);
b. Abstinence-based treatment;
c. Treatment, recovery, or other services provided by states, subdivisions,
community health centers; non-for-profit providers; or for-profit providers;
d. Treatment by providers that focus on OUD treatment as well as treatment by
providers that offer OUD treatment along with treatment for other SUD/MH
condition, co-usage, andf or co-addiction; or
e. Evidence- informed residential services programs, as noted below.
3- Expand telehealth to increase access to treatment for OUD and any co-occurring
suD/MH conditions, co-usage, and/or co-addiction, including MAT, as well as
counseling, psychiatric support, and other treatment and recovery support services.
4. lmprove oversight of Opioid Treatment Programs {OTPs) to assure evidence-based,
evidence-informed, or promising practices such as adequate rnethadone dosing.
5. Support mobile intervention, treatment, and recovery services, offered by qualified
professional and service providers, such as peer recovery coaches, for persons with
OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction and for
persons who have experienced an opioid overdose.
6' Support treatment of mental health trauma resulting from the traumatic experiences
of the opioid user (e.g., violence, sexual assault, human trafficking, or adverse
childhood experiences) and family members (e.g., surviving family members after an
overdose or overdose fatality), and training of health care personnel to identifii and
address such trauma.
7. Support detoxification (detox) and withdrawal management services for persons withouD and any co-occurring sUD/MH conditions, co-usage, andf or co-addiction,
including medical detox, referral to treatment, or connections to other services or
supports.
8' Support training on MAT for health care providers, students, or other supporting
professionals, such as peer recovery coaches or recovery outreach specialists,
including telementoring to assist community-based providers in rural or underserved
areas,
9. Support workforce development for addiction professionals who work with persons
with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction.
10. Provide fellowships for addiction medicine specialists for direct patient care,
instructors, and clinical research for treatments.
11. Provide funding and training for clinicians to obtain a waiver under the federal Drug
Addiction Treatment Act of 2000 (DATA 2000) to prescribe MAT for OUD, and provide
technical assistance and professional support to clinicians who have obtained a DATA
2000 waiver.
12. Support the dissemination of web-based training curricula, such as the American
Academy of Addiction Psychiatry's Provider Clinical Support Service-Opioids web-
based traini ng cu rricu lum and motivational inte rviewin g.
13. Support the development and dissemination of new curricula, such as the American
Academy of Addiction Psychiatry's Provider Clinical Support Service for Medication-
Assisted Treatment
B. SUPPORT PEOPTT IN TREATMENT AND RECOVERY
Support people in treatment for and recovery form OUD and any co-occurring SUD/MH
conditions, co-usage, and/or co-addiction through evidenced-based, evidence-informed, or
promising programs or strategies that may include, but are not limited to, the following:
1. Provide the full continuum of care of recovery services for OUD and any coOoccurrinf
SUD/MH condition, co-usagef and/or co-addiction, including supportive housing,
residential treatment, medical detox services, peer support services and counseling,
community navigators, case management, and connections to community-based
services.
Z. Provide counseling, peer-support, recovery case management and residential
treatment with access to medications for those who need it to persons with OUD and
any co-occurring SUD/MH conditions, co-usage, and/or co-addiction.
3. Provide access to housing for people with OUD and any co-occurring SUD/MH
conditions, co-usage, and/or co-addiction, including supportive housing, recovery
housing housing assistance programs, or training for housing providers.
4. Provide community support services. lncluding social and legal services, to assist in
deinstitutionalizing persons with OUD and any co-occurring SUD/MH conditions, co-
usage, and f or co-addiction.
5. Support or expand peer-recovery centers, which may include support groups, social
events, computer access, or other services for persons with OUD and any co-occurring
SUD/MH conditions, co-usage, andlor co-addiction.
6. Provide employment training or educational services for persons in treatment for or
recovery form OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-
addiction.
7, ldentify successful recovery programs such as physician, pilot, and college recovery
programs, and provide support and technical assistance to increase the number and
capacity of high-quality programs to help those in recovery.
8. Engage non-profits, faith-based communities, and community coalitions to support
people in treatment and recovery and to support family members in their efforts to
manage the opioid user in the family.
9. Provide training and development of procedures for government staff to
appropriately interact and provide social and other services to current and recovering
opioid users, including reducing stigma.
10. Support stigma reduction efforts regarding treatment and support for persons with
OUD, including reducing the stigma on effective treatment.
c.
Provide connections to care for people who have - or are at risk of developing - OUD and any
co-occurring SUD/MH conditions, co-usage, and/or co-addiction through evidence-based,
evidence-informed, or promising programs or strategies that may include, but are not limited
to, the following:
1. Ensure that health care providers are screening for OUD and other risk factors and
know how to appropriately counsel and treat (or refer if necessary) a patient for OUD
treatment.
2. Support Screening, Brief lntervention and Referral to Treatment (SBIRT) programs to
reduce the transition from use to disorders.
3. Provide training and long-term implementation of SBIRT in key systems (health,
schools, colleges, criminal justice, and probation), with a focus on youth and young
adults when transition from misuse to opioid disorder is common,4. Purchase automated versions of SBIRT and support ongoing costs of the technology.
5. Support training for emergency room personnel treating opioid overdose patients on
post-discharge planning including community referrals for MAT, recovery case
management or support services.
5. Support hospital programs that transition persons with OUD and any co-occurring
SUD/MH conditions, co-usage, and/or co-addiction, or person who have experienced
an opioid overdose, into community treatment or recovery services through a bridge
clinic or similar approach.
7. Support crisis stabilization centers that serve as an alternative to hospitat emergency
departments for persons with OUD and any co-occurring SUD/MH conditions,
co=usage, and /or co-addiction or persons that have experienced an opioid overdose.8' Support the work of Emergency Medical Systems, including peer support specialists,
to connect individuals to treatment or other appropriate services following an opioid
overdose or other opioid=reiated adverse event.
9. Provide funding for peer support specialists or recovery coaches in emergency
departrnents, detox facilities, recovery centers, recovery housing, or similar settings;
offer services, supports, or connections to care to persons with OUD and any co-
occurring SUD/MH conditions, co-usage, and/or co-addiction or to persons who have
experienced an opioid overdose.
10, Provide funding for peer navigators, recovery coaches, care coordinators, or care
managers that offer assistance to persons with OUD and any co-occurring SUDIMH
conditions, co-usage, and/ar co-addiction or to person who have experienced on
opioid overdose.
11. Create or support school-based contacts that parents can engage with to seek
irnmediate treatrnent services for their child; and support prevention, intervention,
treatment, and recovery programs focused on young people.
12. Develop and support best practices on addressing ouD in the workplace.
13. support assistance programs for health care providers with ouD.
14' Engage non-profits and the faith communlty as a system to support outreach for
treatment.
15. Support centralized call centers that provide information and connections to
appropriate services and supports for person s with OUD and any co-occurring
SUD/MH conditions, co-usage, an/or co-addiction.
16. Create or support intake and call centers to facilitate education and access to
treatment, prevention, and recovery services for persons with ouD and any co_
occu rring SU D/M H condition, co-usage, and/or co-addictio n,
17. Develop or support a National Treatment Availability Clearing house a
multistate/nationally accessible database whereby health care providers can list
locations for currently available in-patient and out-patient OUD treatment services
that are accessible on a real-time basis by persons who seek treatment.
D. ADDRESS THE NEEDS OF CRIMINAL-JUSTICE-INVOLVED PERSONS
Address the needs of persons with OUD and any co-occurring SUD/MH conditions, co-usage,
and/or co-addiction who are involved - or are at risk of becoming involved - in the criminal
justice system through evidence-based, evidence-informed, or promising programs or
strategies that may include, but are not limited to, the following:
1. Support pre-arrest or post-arrest diversion and deflection strategies for persons with
OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction,
including established strategies such as:
a. Self-referral strategies such as the Angel Programs or the Police Assisted Addiction
Recovery lnitiative (PAARI);
b. Active outreach strategies such as the Drug Abuse Response Team (DART) model;
c. "Naloxone Plus" strategies, which work to ensure that individuals who have
received naloxone to reverse the effects of an overdose are then linked to
treatment programs or other appropriate services;
d. Officer prevention strategies, such as the Law Enforcement Assisted Diversion
(LEAD)model;
e. Officer intervention strategies such as the Leon County, Florida Adult Civil Citation
Network or the Chicago Westside Narcotics Diversion to Treatment lnitiative;
f. Co-responder and/or alternative responder models to address OUD-related 911
calls with greater 5UD expertise and to reduce perceived barriers associated with
law enforcement 911 responses; or
g. County prosecution diversion programs, including diversion officer salary, only for
counties with a population of 50,000 or less. Any diversion services in matters
involving opioids must include drug testing, monitoring, ortreatment.
2. Support pre-trial services that connect individuals with OUD and any co-occurring
SUD/MH conditions, co-usage, and/or co-addiction to evidence-informed treatment,
including MAT, and related services.
3. Support treatment and recovery courts for persons with OUD and any co-occurring
SUD/MH conditions, co-usage, andf or co-addiction, but only if these courts provide
referra ls to evidence-info rmed treatm ent, including MAT.
4. Provide evidence-informed treatment, including MAT, recovery support, or other
appropriate services to individuals with OUD and any co-occurring SUD/MH
conditions, co-usage, and/or co-addiction who are incarcerated in jail or prison.
5. Provide evidence-informed treatment, including MAT, recovery support, or other
appropriate services to individuals with OUD and any co-occurring SUD/MH
conditions, co-usage, and/or co-addiction who are leaving jail or prison have recently
left jail or prison, are on probation or parole, are under community corrections
supervision, or are in re-entry programs or facilities.
6. Support critical time interventions (CTl), particularly for individuals living with dual-
diagnosis OUD/serious mental illness, and services for individuals who have
immediate risks and service needs and risks upon release from correctional settings.7. Provide training on best practices for addressing the needs of criminal-justice-
involved persons with oUD and any co-occurring suD/MH conditionq co-usage,
and/or co-addiction to law enforcement, correctional, or judicial personnel or to
providers of treatment, recovery, case management, or other services offered in
connection with any of the strategies described in this section.
E.
I NCLUDING BABI E5 WTTH NEONATAT ABSNilENCE SYNDROME
Address the needs of pregnant or parenting women with OUD and any co-occurring SUD/MH
conditions, co-usage, and/or co-addiction, and the needs of their families, including babieswith neonatal abstinence syndrome, through evidence-based, evidence-informed, or
promising prograrns or strategies that may include, but are not limited to, the following:
1" Support evidence-based, evidence-informed, or promising treatment, including MAT,
recovery services and supports, and prevention services for pregnant women - or
women who could become pregnant - who have OUD and y any co-occurring 5UD/MH
conditions, co-usage, and/or co-addiction, and other measures to educate and
provide support to families affected by Neonatal Abstinence syndrome.2. Provide training for obstetricians or other healthcare personnel that work with
pregnant women and their families regarding treatment of OUD and any co-occurring
SU D/M H cond itions, co-usage, a n d/or co-addiction.
3' Provide training to health care providers who work with pregnant or parenting
women on best practices for compliance with federal requirements that children born
with Neonatal Abstinence Syndrome get referred to appropriate services and receive
a plan of safe care.
4. Provide enhanced support for children and family members suffering trauma as a
result of addiction in the family; and offer trauma-informed behavioral health
treatment for adverse childhood events.
5. offer enhanced family supports and home-based wrap-around services to persons
with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction,
including but not limited to parent skills training.
6. Support for Children's Services - Fund additional positions and services, including
supportive housing and other residential services, relating to children being removed
from the home and/or placed in foster care due to custodial opioid use.
PART TWO: PREVENTION
F. PREVENT OVER-PRESCn|B|NG ANp ENSURE APPBOPRLATE PRESCRIBING AND
DISPENSING OF OPIODS
Support efforts to prevent over-prescribing and ensure appropriate prescribing and dispensing
of opioids through evidence-based, evidence-informed, or promising programs or strategies that
may include, but are not limited to, the following:
L. Training for health care providers regarding safe and responsible opioid prescribing,
dosing, and tapering patients off opioids.
2. Academic counter-detailing to educate prescribers on appropriated opioid
prescribing.
3. Continuing Medical Education (CME) on appropriate prescribing of opioids.
4. Support for non-opioid pain treatment alternatives, including training providers to
offer or refer to multi-modal, evidence-informed treatment of pain.
5. Support enhancements or improvements to Prescription Drug Monitoring Programs
(PSMPs), including but not limited to improvements that:
A. lncrease the number of prescribers using PDMPs;
B. lmprove point-of-care decision-making by increasing the quantity, quality, or
format of data available to prescribers using PDMPs or by improving the
interface that prescribers use to access PDMP data, or both; or
C. Enable states to use PDMP data in support of surveillance or intervention
strategies, including MAT referrals and follow-up for individuals identified
within PDMP data as likely to experience OUD.
6. Development and implementation of a national PDMP - Fund development of a
multistate/national PDMP that permits information sharing while providing
appropriate safeguards on sharing of private health information, including but not
limited to:
a. lntegration of PDMP data with electronic health records, overdose episodes,
and decision support tools for health care providers relating to OUD.
b. Ensuring PDMPs incorporate available overdose/naloxone deployment data,
including the United States Department of Transportation's Emergency
Medical Technician overdose database.
7. lncrease electronic prescribing to prevent diversion or forgery.
8. Educate Dispensers on appropriate opioid dispensing.
G. PREVENT MTSUSE OF OP|O|DS
Support efforts to discourage or prevent misuse of opioids through evidence-based,
evidence-informed, or promising programs or strategies that may include, but are not limited
to, the following:
1. Corrective advertising or affirmative public education campaigns based on evidence.
2. Public education relating to drug disposal.
3. Drug take-back disposal or destruction programs.
4. Fund community anti-drug coalitions that engage in drug prevention efforts.5' Support community coalitions in implementing evidence-informed prevention, such
as reduced social access and physical access, stigma reduction - including staffing,
educational campaigns, support for people in treatment or recovery, or training of
coalitions in evidence-informed implementation, including the strategic preveniion
Framework developed by the U.S. Substance Abuse and Mental Health Services
Ad min istration (SAM HSA).
6' Engage non-profits and faith-based communities as systems to support prevention.7' Support evidence-informed school and community education programs and
campaigns for students. Families, school employees, schoolathletic prog."rr, parent-
teacher and student associations, and others.8' School-based or youth-focused programs or strategies that have demonstrated
effectiveness in preventing drug misuse and seem likely to be effective in preventing
the uptake and use of opioids.
9. Support community-based education or intervention services for families, youth, and
adolescents at risk for ouD and any co-occurring suD/MH conditions, co-usage,
and/or co-addiction.
10. Support evidence-informed programs or curricula to address mental health needs ofyoung people who may be at risk of misusing opioids or other drugs, including
emotional modulation and resilience skills.
1'1. Support greater access to mental health services and supports for young people,
including services and supports provided by school nurses or other school staff, to
address mental health needs in young people that (when not properly addressed)
increase the risk of opioid or other drug misuse.
H.
Support efforts to prevent or reduce overdose deaths or other opioid-related harms through
evidence-based, evidence-informed, or promising programs or strategies that may include,
but are not limited to, the following:
1. lncrease availability and distribution of naloxone and other drugs that treat overdosesfor first responders, overdose patients, opioid users, families and friends of opioid
users, schools, cornmunity navigators and outreach workers, drug offenders upon
release from jail/prison, or other members of the general public.2' Provision by public health entities of free naloxone to anyone in the community,
including but not limited to provision of intra-nasal naloxone in settings where other
options are not available or allowed.
3' Training and education regarding naloxone and other drugs that treat overdoses forfirst responders, overdose patients, patients taking opioids, families. schools, andother members of the general public.
4- Enable school nurses and other school staff to respond to opioid overdoses, andprovide them with naloxone, training, and support.
5. Expand, improve, or develop data tracking software and applications for
overdoses/naloxone revivals.
6. Public education relating to emergency responses to overdoses.
7. Public education relatingto immunity and Good Samaritan laws,
8. Educate first responders regardingthe existence and operation of immunity and Good
Samaritan laws.
9. Expand access to testing and treatment for infectious diseases such as HIV and
Hepatitis C resulting from intravenous opioid use.
L0. Support mobile units that offer or provide referrals to treatment, recovery supports,
health care, or other appropriate services to persons that use opioids or persons with
OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addaction.
11-. Provide training in treatment and recovery strategies to health care providers,
students, peer recovery coaches, recovery outreach specialists, or other professionals
that provide care to persons who use opioids or persons with OUD and any co-
occurring 5U D/M H conditions, co-usage, and/o r co-add iction.
12. Support Screening for fentanyl in routine clinical toxicology testing
PART THREE: OTHER STRATEGIES
I. FIRST RESPONDERS
ln addition to items C8, DL through D7, Ht, H3 and H8, support the following:
1. Current and future law enforcement expenditures relating to the opioid epidemic.
2. Educate law enforcement or other first responders regarding appropriate practices
and precautions when dealing with fentanyl or other drugs.
I. LEADERSHIP, PTANNING,AND COORDINATION
Support efforts to provide leadership, planning, and coordination to abate the opioid
epidemlc through activities, programs, or strategies that may include, but are not limited to,
the following:
1. Community regional planning to identify goals for reducing harms related to the
opioid epidemic, to identify areas and populations with the greatest needs for
treatment intervention services, or to support other strategies to abate the opioid
epidemic described in this opioid abatement strategy list.
2. A government dashboard to track key opioid-related indicators and supports as
identified through collaborative community processes.
3.lnvest in infrastructure or staffing at government or not-for-profit agencies to support
collaborative, cross-system coordination with the purpose of preventing
overprescribing, opioid misuse, or opioid overdoses, treating those with oUD and any
co-occurring suD/MH conditions, co-usage, andlor co-addiction, supporting them in
treatment or recovery, connecting them to care, or implementing other strategies to
abate the opioid epidemic described in this opioid abatement strategy list.
4. Provide resources to staff government oversight and management of opioid
abatement programs.
K. TRAINING
ln addition to the training referred to in various items above, support training to abate the
opioid epidemic through activities, programs, or strategies that may include, but are not
limited to, the following:
1. Provide funding for stafftraining or networking programs and services to irnprove the
capability of government, community, and not-for-profit entities to abate the opioid
crisis.
2. lnvest in infrastructure and staffing for collaborative cross-system coordination to
prevent opioid misuse, prevent overdoses, and treat those with OUD and any co-
occurring SUD/MH conditions, co-usage, andfor co-addiction, or implement other
strategies to abate the opioid epidemic described in this opioid abatement strategy
list (e.g., health care, primary care, pharmacies, pDMps, etc.)
t. RESEARCH
Support opioid abatement research that may include, but is not limited to, the following:
L' Monitoring, surveillance, and evaluation of programs and strategies described in this
opioid abatement strategy list.
2. Research non-opioid treatment of chronic pain
3. Research on improved service delivery for modalities such as SBIRT that demonstrate
promising but mixed results in populations vulnerable to opioid use disorders.4. Research on innovative supply-side enforcement efforts such as improved detection
of mail-based delivery of synthetic opioids.
5. Expanded research on swift/ceftain/fair models to reduce and deter opioid misuse
within criminal justice populations that build upon promising approaches used to
address other substances (e.g. Hawaii HOpE and Dakota 24/7).6' Research on expanded modalities such as prescription methadone that can expand
access to MAT.
EXHIBIT C
COMMUNITY HEALTH IMPROVEMENT PLAN AND ONE WASHINGTON MOU OPIOID ABATEMENT
STRATEGI ES CROSSWALK ANALYSIS
Research
Training
Leaders hip, ptanning and
coordination
First responders
overdose deaths andPrevent
other harms
misuse of opioidsPrevent
over-prescribing and
ensure appropriate
prescribing and dispensing
of oids
Prevent
Address the needs of
pregnant or parenting
women and their famities,
inctuding babies with
neonataI abstinence
drome
Address the needs of
cri m in a t-j ustice-i nvotved
rSONS
peopte who need
hetp to the hetp they need
(connections to care)
Connect
pport peopte in treatment
and recovery
Su
Treat opioid use disorder
(ouD)
Co ntractua[[y Attowabte
Activity
Goal2.1
Goal2.1
Goal2.2
Goal2.2
Goat2.1
Goal 1.3
Community-
ldentified Priority
No
partiat
No
No
partiat
Yes
No
partiat
No
Partiat
Yes
Yes
Alignment?
addressed in the CHlp.Not
for cross-system cotlaboration and CHlp
tatks about sustained cross-sector
co[[aboration.
MOU tatks about investing in infrastructure
addressed in the CHlp.Not
Chip does not mention first responder
training.
public education and this
coutd atign with resource guide and/or
MOU discusses
conversationscom
programming and behaviorat heatth
screenings in CHlp if atigned with the goat of
OUD prevention woutd fatt within this
Schoot
does not inctude changes inCHIP
prescribing process.
e crossover with both Goat 3.2There coutd b
and Goat 3.8.
s not mentioned in the CHlpThis i
or are at risk of developing _ OUD and any
co-occurri conditions."
may
Kittita D
tign with
county
th e
priority
MOU "pe o
poputat
pte
ions
who
(cH P)
have
directty mentioned in
both. Peer-sup
with Act 2.1.3
port (MOU)cou[d be atigned
Stigma reduction
"support mobite intervention" (mou) atigns
with "expand mobite and free ctinic
ce"
"Expand avaitabitity of treatment" and
/ Gaps / OpportunitiesNotes
Community Heatth lmprovement Ptan Goats
Goat 3.3
Goat 3.2
Goat 3.1
Goal2.2
Goal2.t
Goat 1.3
Goal7.2
Goat 1.1
lncrease age-specific mentaI heatth and substance use services and providers
lncrease communication between a[[ community partners, parents, and families to
address adotescent specific needs
Foster community resitience by increasing the number of protective factors through
poticymakers and other community groups to improve access to recreation and activities, chitdcare
facilities, mentoring, and other prevention resources
lncrease evidence-based prevention strategies to identified priority poputations
Sustained cross-sector cotlaboration for stigma reduction and resource awareness
Addressing barriers to accessing heatthcare services (tanguage, location, literacy, stigma,
insurance, culturaI competency, transportation, technotogy, nontraditionaI heatthcare needs)
conduct an assessment on heatthcare workforce needs and improvement strategies
Support the effofis around coordinating seruices for individuats with comptex heatth
and sociaI needs